Historical source coverage

2022, page 2

223 selected records with a cited source date in 2022, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2022 by record type

4 types

February 2022

7 records on this page

Literature metadata · Melanotan II

Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.

PubMed lists PMID 34464955 in Dermatology (Basel, Switzerland) as Journal Article, with publication-date metadata of 2021-08-31 (day precision). PeptideScanner associated the retained record with the identity slug melanotan-ii. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

Vosoritide: First Approval.

PubMed lists PMID 34694597 in Drugs as Journal Article, Review, with publication-date metadata of 2021-11 (month precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Teduglutide

ClinicalTrials.gov record NCT02980666

PeptideScanner retained ClinicalTrials.gov record NCT02980666 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-02-02, and PeptideScanner's reviewed identity mapping was teduglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · FOXO4-DRI

Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes.

PubMed lists PMID 33996787 in Frontiers in bioengineering and biotechnology as Journal Article, with publication-date metadata of 2021-04-29 (day precision). PeptideScanner associated the retained record with the identity slug foxo4-dri. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

January 2022

16 records on this page

Literature metadata · MK-677

Characterization of equine liver microsome-generated metabolites of growth hormone secretagogue small molecule ibutamoren.

PubMed lists PMID 34542924 in Rapid communications in mass spectrometry : RCM as Journal Article, with publication-date metadata of 2021-12-15 (day precision). PeptideScanner associated the retained record with the identity slug mk-677. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Daptomycin

Federal Register notice 2022-01693

The Federal Register published notice 2022-01693, attributed to FDA and its parent HHS department, on 2022-01-28. Its official title is “21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria Web Page; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Daptomycin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Bremelanotide

Bremelanotide for Treatment of Female Hypoactive Sexual Desire.

PubMed lists PMID 35076581 in Neurology international as Journal Article, Review, with publication-date metadata of 2022-01-04 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03548987

PeptideScanner retained ClinicalTrials.gov record NCT03548987 at 2026-07-30T19:44:52.954Z. Its registry update date was 2022-01-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Humanin

Humanin and Alzheimer's disease: The beginning of a new field.

PubMed lists PMID 34626746 in Biochimica et biophysica acta. General subjects as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2021-10-07 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Humanin

The role of humanin in natural stress tolerance: An underexplored therapeutic avenue.

PubMed lists PMID 34626747 in Biochimica et biophysica acta. General subjects as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2021-10-07 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Carfilzomib

Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with…

PubMed lists PMID 34774221 in The Lancet. Oncology as Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-11-11 (day precision). PeptideScanner associated the retained record with the identity slug carfilzomib. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis.

PubMed lists PMID 33825489 in Circulation research as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-04-07 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT03262610

PeptideScanner retained ClinicalTrials.gov record NCT03262610 at 2026-07-30T19:44:52.963Z. Its registry update date was 2022-01-04, and PeptideScanner's reviewed identity mapping was setmelanotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT03659578

PeptideScanner retained ClinicalTrials.gov record NCT03659578 at 2026-11-15T22:10:40.222Z. Its registry update date was 2022-01-03, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→